Spontaneous rectus sheath hematoma during rivaroxaban therapy

Rivaroxaban is an oral anticoagulant agent that directly inhibits Factor Xa and interrupts both the intrinsic and extrinsic pathway of the coagulation cascade and is currently indicated for use in patients for atrial fibrillation and prophylaxis of deep venous thrombosis. The present case reports of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kocayigit, Ibrahim, Can, Yusuf, Sahinkus, Salih, Aydın, Ercan, Vatan, Mehmet Bulent, Kılıc, Harun, Gunduz, Huseyin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Drug Watch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071715/
https://www.ncbi.nlm.nih.gov/pubmed/24987185
http://dx.doi.org/10.4103/0253-7613.132193
_version_ 1782322843396079616
author Kocayigit, Ibrahim
Can, Yusuf
Sahinkus, Salih
Aydın, Ercan
Vatan, Mehmet Bulent
Kılıc, Harun
Gunduz, Huseyin
author_facet Kocayigit, Ibrahim
Can, Yusuf
Sahinkus, Salih
Aydın, Ercan
Vatan, Mehmet Bulent
Kılıc, Harun
Gunduz, Huseyin
author_sort Kocayigit, Ibrahim
collection PubMed
description Rivaroxaban is an oral anticoagulant agent that directly inhibits Factor Xa and interrupts both the intrinsic and extrinsic pathway of the coagulation cascade and is currently indicated for use in patients for atrial fibrillation and prophylaxis of deep venous thrombosis. The present case reports of spontaneous rectus sheath hematoma during rivaroxaban therapy for atrial fibrillation in a 75-year-old woman.
format Online
Article
Text
id pubmed-4071715
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-40717152014-07-01 Spontaneous rectus sheath hematoma during rivaroxaban therapy Kocayigit, Ibrahim Can, Yusuf Sahinkus, Salih Aydın, Ercan Vatan, Mehmet Bulent Kılıc, Harun Gunduz, Huseyin Indian J Pharmacol Drug Watch Rivaroxaban is an oral anticoagulant agent that directly inhibits Factor Xa and interrupts both the intrinsic and extrinsic pathway of the coagulation cascade and is currently indicated for use in patients for atrial fibrillation and prophylaxis of deep venous thrombosis. The present case reports of spontaneous rectus sheath hematoma during rivaroxaban therapy for atrial fibrillation in a 75-year-old woman. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4071715/ /pubmed/24987185 http://dx.doi.org/10.4103/0253-7613.132193 Text en Copyright: © Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Drug Watch
Kocayigit, Ibrahim
Can, Yusuf
Sahinkus, Salih
Aydın, Ercan
Vatan, Mehmet Bulent
Kılıc, Harun
Gunduz, Huseyin
Spontaneous rectus sheath hematoma during rivaroxaban therapy
title Spontaneous rectus sheath hematoma during rivaroxaban therapy
title_full Spontaneous rectus sheath hematoma during rivaroxaban therapy
title_fullStr Spontaneous rectus sheath hematoma during rivaroxaban therapy
title_full_unstemmed Spontaneous rectus sheath hematoma during rivaroxaban therapy
title_short Spontaneous rectus sheath hematoma during rivaroxaban therapy
title_sort spontaneous rectus sheath hematoma during rivaroxaban therapy
topic Drug Watch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071715/
https://www.ncbi.nlm.nih.gov/pubmed/24987185
http://dx.doi.org/10.4103/0253-7613.132193
work_keys_str_mv AT kocayigitibrahim spontaneousrectussheathhematomaduringrivaroxabantherapy
AT canyusuf spontaneousrectussheathhematomaduringrivaroxabantherapy
AT sahinkussalih spontaneousrectussheathhematomaduringrivaroxabantherapy
AT aydınercan spontaneousrectussheathhematomaduringrivaroxabantherapy
AT vatanmehmetbulent spontaneousrectussheathhematomaduringrivaroxabantherapy
AT kılıcharun spontaneousrectussheathhematomaduringrivaroxabantherapy
AT gunduzhuseyin spontaneousrectussheathhematomaduringrivaroxabantherapy

Ejemplares similares